CHJ.35261
Albumin solution human
--
--
Ordering
Available Variants50 mL
CHJ.35261-50mL
Price
€236.80
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
50 mL | CHJ.35261-50mL | €236.80 |
10% in 0.85% sodium chloride and 0.05% sodium azide, aseptically filled
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| CAS Number | 70024-90-7 |
|---|---|
| UNSPSC Code | 12352202 |
| NACRES | NA.25 |
| MDL number | MFCD00081418 |
| eCl@ss | 42010201 |
| Biological source | human |
| Form | liquid |
| Technique(s) | ELISA: suitable, tissue culture: suitable, western blot: suitable |
| Impurities | HIV I and HIVII, HCV and HBsAg, tested negative |
| Concentration | 10% in 0.85% sodium chloride and 0.05% sodium azide, 9.5-11.4% protein (biuret) |
Safety Information Handling visibility
| Storage Class | 10 - Combustible liquids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
Albumin solution human, with a CAS number of 70024-90-7, is a sterile solution of serum albumin derived from human blood. It is used in medical settings to treat or prevent shock following severe blood loss, burns, surgery, or other causes of hypovolemia. The solution has a colloid osmotic pressure similar to that of human plasma, making it an effective volume expander. Albumin solution human is typically administered intravenously and is often used in critical care and surgical settings. Its use can help maintain cardiac output and prevent organ failure in patients with severe hypovolemia. The solution is usually provided in concentrations of 5% or 25% and is available in various packaging sizes to accommodate different clinical needs. Its safety and efficacy have been well established in numerous clinical studies.
